ANVISA

Anvisa Directors Signal in Meeting with Associations that Agency Should Meet STJ Deadline to Regulate Cannabis Cultivation

Anvisa Directors Signal in Meeting with Associations that Agency Should Meet STJ Deadline to Regulate Cannabis Cultivation

30/09/2025

Representatives of associations who participated in the meeting with the entity confirmed the delivery of the draft ordinance by September 30; Anvisa has not yet officially stated whether it will comply with the deadline set by the Judiciary, which ends today

Anvisa and Embrapa evaluate authorization for cannabis research in Brazil

Anvisa and Embrapa evaluate authorization for cannabis research in Brazil

25/09/2025

Meeting aligned strategies for the development of technical and scientific knowledge about the plant, focusing on its medicinal and industrial potential

Anvisa prohibits cannabis products; companies involved claim outdated information

Anvisa prohibits cannabis products; companies involved claim outdated information

23/09/2025

Agency points out irregular sale on website, but former partner claims page has been offline for over a year

Public participation in Anvisa's regulatory agenda continues until September 15

Public participation in Anvisa's regulatory agenda continues until September 15

12/09/2025

Public consultation allows society to give opinions on the agency's priorities for the next two years; preliminary list does not include cannabis

More than 500 companies offer cannabis products to Brazil through importation; products now exceed 600

More than 500 companies offer cannabis products to Brazil through importation; products now exceed 600

11/09/2025

Anvisa points out the USA as the main supplier, followed by Canada, Colombia, and Uruguay

Reblas Network includes cannabis product analysis; Brazil has 16 accredited laboratories

Reblas Network includes cannabis product analysis; Brazil has 16 accredited laboratories

11/09/2025

Published by Anvisa, the new resolution expands the scope of the network of analytical laboratories and reinforces the quality control of cannabis-based products in the country

Reblas Network includes cannabis product analysis; Brazil has 16 accredited laboratories

Reblas Network includes cannabis product analysis; Brazil has 16 accredited laboratories

11/09/2025

Published by Anvisa, the new resolution expands the scope of the network of analytical laboratories and reinforces the quality control of cannabis-based products in the country

Reblas Network includes cannabis product analysis; Brazil has 16 accredited laboratories

Reblas Network includes cannabis product analysis; Brazil has 16 accredited laboratories

11/09/2025

Published by Anvisa, new resolution expands the scope of the network of analytical laboratories and reinforces the quality control of cannabis-based products in the country

Anvisa has new approved directors

Anvisa has new approved directors

21/08/2025

Confirmed appointments include Leandro Safatle, Thiago Campos, and Daniela Cerqueira

Anvisa Regulatory Agenda 2026 - 2027 opens space for society suggestions, including on cannabis

Anvisa Regulatory Agenda 2026 - 2027 opens space for society suggestions, including on cannabis

20/08/2025

Population and regulated sectors have the opportunity to indicate topics of interest for the next biennium

Proposal to regulate cannabis cultivation is taken off Anvisa's meeting agenda

Proposal to regulate cannabis cultivation is taken off Anvisa's meeting agenda

13/08/2025

Decision postpones vote on new rules for cultivating low-THC varieties; new date for analysis not yet defined

Request for cannabis-based medicine without registration at Anvisa must be judged by the Federal Court

Request for cannabis-based medicine without registration at Anvisa must be judged by the Federal Court

13/08/2025

STJ decision reinforces federal jurisdiction for actions involving unregistered drugs at the regulatory agency